M asateru Uno is the founder and chairman of Cosmos Pharmaceutical, a highly successful discount drugstore chain based in Fukuoka, Japan. He established the company in 1983 and pioneered a business model focused on large-format stores in suburban and rural locations, offering a wide range of products from pharmaceuticals and cosmetics to food and daily necessities at competitive prices. This strategy allowed Cosmos to dominate markets in Kyushu and expand rapidly across western Japan.
Uno's approach of owning the land for his stores to reduce costs and maintain high profitability has been a key driver of the company's success. Cosmos Pharmaceutical is listed on the Tokyo Stock Exchange and operates over 1,500 stores. Masateru Uno shares his fortune with his family, and his son, Yukitaka Uno, is actively involved in the business as a director, ensuring the continuity of the family's leadership in the Japanese retail sector.
Advertisement
Masateru Uno is a Japanese businessman, the Founder and Chairman of Cosmos Pharmaceutical (TYO: 3349), a major retail chain that operates over 1,500 drugstores in Japan. The company sells medicines, cosmetics, food, and beverages.
He founded the company in 1997. His son, Yukitaka, is a director of the company and heads product development.
Masateru Uno's career is defined by the successful expansion of Cosmos Pharmaceutical into one of Japan's largest drugstore chains. By rapidly scaling to over 1,500 locations, the company achieved massive market penetration in the retail and wellness sectors.
The company went public on the Tokyo Stock Exchange (TYO) in 2013. His structural contribution is tied to building a successful retail model focused on essential goods. The family maintains control, with his son Yukitaka overseeing product development.
Advertisement
Founds Cosmos Pharmaceutical.
Cosmos Pharmaceutical executes its IPO.
Continues as Chairman, guiding the retail chain.
Masateru Uno's wealth is concentrated in his family's controlling stake in the publicly traded retail giant, Cosmos Pharmaceutical.
Advertisement
Advertisement
No publicly available quotes.
Advertisement
+0.56% | +$10.02M
-0.34% | -$4.97M
This profile is compiled from verified biographical and financial records:
All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.
If you find any inaccuracies, please report them to admin@redcarpetlife.in
Sponsored Content